IV BUSULFAN-BASED REDUCED INTENSITY REGIMEN (RIC) BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IS WELL TOLERATE AND EFFECTIVE IN PATIENTS WITH HEMATOLOGICAL DISEASES

被引：0
|
作者：
Castagna, L. [1 ]
Furst, S. [1 ]
El-Cheikh, J. [1 ]
Faucher, C. [1 ]
Vey, N. [1 ]
Bouabdallah, R. [1 ]
Stoppa, A. -M [1 ]
Mohty, M. [2 ]
Chabannon, C. [1 ]
Esterni, B. [1 ]
Blaise, D. [1 ]
机构：
[1] Inst Paoli Calmettes, Marseille, France
[2] CHU Hotel Dieu, Nantes, France
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.417
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
373
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [11] Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: Myeloablation with reduced toxicity
    Shimoni, A
    Bielorai, B
    Toren, A
    Hardan, I
    Avigdor, A
    Yeshurun, M
    Ben-Bassat, I
    Nagler, A
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (05) : 428 - 434
  • [12] Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
    Kröger, N
    Bornhäuser, M
    Ehninger, G
    Schwerdtfeger, R
    Biersack, H
    Sayer, HG
    Wandt, H
    Schäfer-Eckardt, K
    Beyer, J
    Kiehl, M
    Zander, AR
    ANNALS OF HEMATOLOGY, 2003, 82 (06) : 336 - 342
  • [13] Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
    Dennison, David
    Al Farsi, Khalil
    Al Huneini, Mohammed
    Al Khabori, Murtadha
    Rawas, Abdulhakeem
    Al Shukri, Maryam
    Al Zadjali, Shoaib
    Tauro, Melanie
    Misquith, Rhea
    Al Riyami, Arwa Z.
    Anil, Pathare
    Al Habsi, Yusra
    Al Lawati, Aqeela
    Al Mahrizi, Rahma
    Krishnamoorthy, Rajagopal
    Al Kindi, Salam
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S285 - S286
  • [14] Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
    N. Kröger
    M. Bornhäuser
    G. Ehninger
    R. Schwerdtfeger
    H. Biersack
    H. G. Sayer
    H. Wandt
    K. Schäfer-Eckardt
    J. Beyer
    M. Kiehl
    A. R. Zander
    Annals of Hematology, 2003, 82 : 336 - 342
  • [15] THE EFFECT OF OVERWEIGHT AND OBESITY ON INTRAVENOUS (IV) BUSULFAN METABOLISM IN CHILDREN UNDERGOING REDUCED INTENSITY CONDITIONING (RIC) FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Browning, B.
    Thormann, K.
    Coyne, K.
    Kletsel, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 70 - 70
  • [16] Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT)
    Le Bourgeois, Amandine
    Lestang, Elsa
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Blin, Nicolas
    Clavert, Aline
    Tessoulin, Benoit
    Dubruille, Viviane
    Mahe, Beatrice
    Roland, Virginie
    Gastinne, Thomas
    Le Gouill, Steven
    Moreau, Philippe
    Mohty, Mohamad
    Planche, Lucie
    Chevallier, Patrice
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (03) : 177 - 186
  • [17] Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen
    Behfar, Maryam
    Koochakzadeh, Lili
    Yazdanian, Nafise
    Salajegheh, Pourya
    Rostami, Tahereh
    Khodayari-Namini, Nazanin
    Ghavamzadeh, Ardeshir
    Hamidieh, Amir Ali
    TURKISH JOURNAL OF PEDIATRICS, 2019, 61 (03) : 407 - 412
  • [18] COMPARISON OF IV BUSULFAN AND FLUDARABINE VS IV BUSULFAN AND CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN IN MYELOABALTIVE ALLOGENEIC STEM CELL TRANSPLANTATION
    de Villambrosia, S. Gonzalez
    Moreto, A.
    Nunez, J.
    Bermudez, A.
    Yanez, L.
    Insunza, A.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 142 - 142
  • [19] EVALUATION OF BUSULFAN'S DOSE-INTENSITY IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION (ASCT) WITH TWO DIFFERENT FLUDARABINE/BUSULFAN/ATG (FBA)-BASED REDUCED INTENSITY CONDITIONING (RIC) REGIMENS
    Hamadani, M.
    Craig, M.
    Abraham, J.
    Tse, W.
    Cumpston, A.
    Stotler, C. J.
    Remick, S. C.
    Bunner, P.
    Leadmon, S.
    Elder, P.
    Hofmeister, C.
    Penza, S.
    Andritsos, L.
    Blum Benson, W.
    D. M., Jr.
    Devine, S. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S280 - S280
  • [20] Allogeneic reduced intensity conditioning regimen haematopoietic stem cell transplantation
    Fürst, S
    Dubois, V
    Michallet, AS
    Nicolini, F
    Thomas, X
    Troncy, J
    Rafii, H
    Gebuhrer, L
    Michallet, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S329 - S329
12345